-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Li Zhihong, Vice Chairman of the Standing Committee of the Municipal People’s Congress, visited Shijiazhuang No. 4 Pharmaceutical for a research visit.
Category:
Time：2020-05-27
On May 26, Li Zhihong, Deputy Director of the Standing Committee of the Shijiazhuang Municipal People’s Congress, visited Shijiazhuang Sihua Pharmaceutical Co., Ltd. to learn about the company’s ongoing epidemic prevention and control measures as well as its progress in resuming and reaching full production capacity.
On May 26, Li Zhihong, Deputy Director of the Standing Committee of the Shijiazhuang Municipal People's Congress, visited Shijiazhuang Sihua Pharmaceutical Co., Ltd. to learn about the company’s ongoing epidemic prevention and control measures as well as its progress in resuming and reaching full production capacity.
“How are things going with production and operations? Have you encountered any difficulties? What kind of support do you need?” Li Zhihong asked with great concern about the company’s current production and operational status. Su Xuejun, Chairman of the company, gave Li Zhihong and his delegation a detailed report on the company’s current production and operational situation. Since the outbreak of the pandemic, Shijiazhuang No. 4 Pharmaceutical has strictly implemented the deployment requirements of the municipal Party committee and municipal government, strengthened organizational safeguards, and meticulously planned and arranged both epidemic prevention and control as well as the resumption of work and production, ensuring that the company has achieved both effective epidemic prevention and safe production without compromising either.
After listening to the relevant reports, Li Zhihong “gave a thumbs-up” to Shijiazhuang No.4 Pharmaceutical’s meticulous and solid efforts in epidemic prevention and control, and expressed his appreciation for the company’s approach of overcoming adverse factors to accelerate its development. The epidemic prevention and control measures have been rigorous and effective, and the resumption of work and production has been steady and orderly. Li Zhihong emphasized that we must continue to attach great importance to epidemic prevention and control, remain steadfast in our efforts to contain the virus, proactively address current challenges, boost confidence, focus our efforts precisely, and rise to the occasion, thereby contributing to the high-quality development of the regional economy.
Jin Kerui, a member of the Party Working Committee of the High-tech Zone, and Zhang Wei, Deputy Director of the Bureau of Social Development of the High-tech Zone, along with other relevant leaders, participated in the research visit.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license